United Therapeutics
UTHR
UTHR
355 hedge funds and large institutions have $6.54B invested in United Therapeutics in 2020 Q4 according to their latest regulatory filings, with 68 funds opening new positions, 100 increasing their positions, 140 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 332 → 355 (+23)
1.99% more ownership
Funds ownership: 94.82% → 96.81% (+2%)
29% less repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 140
Holders
355
Holding in Top 10
13
Calls
$39.7M
Puts
$14.7M
Top Buyers
| 1 | +$433M | |
| 2 | +$80.3M | |
| 3 | +$33M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$32M |
| 5 |
SCM
Scopia Capital Management
New York
|
+$31.2M |
Top Sellers
| 1 | -$74.5M | |
| 2 | -$53.1M | |
| 3 | -$48.4M | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$39.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.2M |